Valentine WJ, Hoog M, Mody R, Belger M, et al. Long-term cost-effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the US. Diabetes Obes Metab 2023 Jan 18. doi: 10.1111/dom.14979.
PMID: 36655340